APGE FY 2024 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

APGEApogee Therapeutics, Inc.

$4B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$217M

Net Income

-$182M

EPS (Diluted)

$-3.30

Cash Flow

Operating Cash Flow

-$171M

Free Cash Flow

-$172M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$754M

Total Liabilities

$37M

Stockholders' Equity

$717M

Cash & Equivalents

$142M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$217M	-$93M	-133.2%
Net Income	-$182M	-$84M	-116.9%